Table 3.
Impediments to Use of Pharmacogenomic Information
1. Detection of single polymorphism effects with only small effects on outcomes. |
2. Variability in associations due to the effects of differing genetic backgrounds eg race or ethnicity. |
3. Inadequate reproducibility in multiple populations. |
4. Inadequate informatics support to clinicians. |